久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/14 | 6,960 | 7,010 | 6,850 | 6,870 | -110 | -1.6% | 196,400 |
2018/11/13 | 6,830 | 7,000 | 6,760 | 6,980 | +50 | +0.7% | 193,700 |
2018/11/12 | 6,980 | 7,010 | 6,820 | 6,930 | -110 | -1.6% | 176,900 |
2018/11/09 | 6,980 | 7,070 | 6,850 | 7,040 | +60 | +0.9% | 227,700 |
2018/11/08 | 6,850 | 7,040 | 6,840 | 6,980 | +280 | +4.2% | 288,900 |
2018/11/07 | 6,780 | 6,850 | 6,670 | 6,700 | +70 | +1.1% | 356,300 |
2018/11/06 | 6,370 | 6,660 | 6,370 | 6,630 | +280 | +4.4% | 213,900 |
2018/11/05 | 6,290 | 6,400 | 6,280 | 6,350 | +40 | +0.6% | 163,000 |
2018/11/02 | 6,190 | 6,310 | 6,140 | 6,310 | +140 | +2.3% | 253,900 |
2018/11/01 | 6,270 | 6,330 | 6,150 | 6,170 | -200 | -3.1% | 198,900 |
2018/10/31 | 6,220 | 6,370 | 6,170 | 6,370 | +200 | +3.2% | 255,600 |
2018/10/30 | 6,050 | 6,200 | 6,030 | 6,170 | +100 | +1.6% | 179,000 |
2018/10/29 | 6,260 | 6,280 | 6,070 | 6,070 | -160 | -2.6% | 153,200 |
2018/10/26 | 6,300 | 6,310 | 6,130 | 6,230 | +10 | +0.2% | 201,900 |
2018/10/25 | 6,430 | 6,440 | 6,220 | 6,220 | -310 | -4.7% | 167,500 |
2018/10/24 | 6,530 | 6,580 | 6,440 | 6,530 | +80 | +1.2% | 205,900 |
2018/10/23 | 6,550 | 6,600 | 6,440 | 6,450 | -200 | -3% | 195,600 |
2018/10/22 | 6,680 | 6,700 | 6,540 | 6,650 | -230 | -3.3% | 231,900 |
2018/10/19 | 6,810 | 6,930 | 6,810 | 6,880 | +30 | +0.4% | 147,500 |
2018/10/18 | 7,030 | 7,080 | 6,830 | 6,850 | -80 | -1.2% | 145,400 |
2018/10/17 | 6,920 | 6,970 | 6,870 | 6,930 | +80 | +1.2% | 153,100 |
2018/10/16 | 6,910 | 6,940 | 6,760 | 6,850 | -50 | -0.7% | 194,500 |
2018/10/15 | 6,980 | 7,070 | 6,880 | 6,900 | -200 | -2.8% | 222,200 |
2018/10/12 | 7,270 | 7,280 | 7,000 | 7,100 | -170 | -2.3% | 213,100 |
2018/10/11 | 7,500 | 7,630 | 7,200 | 7,270 | -600 | -7.6% | 282,300 |
2018/10/10 | 7,880 | 7,970 | 7,720 | 7,870 | -50 | -0.6% | 197,000 |
2018/10/09 | 8,440 | 8,470 | 7,890 | 7,920 | -770 | -8.9% | 291,100 |
2018/10/05 | 8,660 | 8,780 | 8,630 | 8,690 | +30 | +0.3% | 136,900 |
2018/10/04 | 9,100 | 9,100 | 8,630 | 8,660 | -380 | -4.2% | 191,600 |
2018/10/03 | 9,140 | 9,260 | 9,020 | 9,040 | -20 | -0.2% | 173,300 |
2018/10/02 | 8,760 | 9,070 | 8,730 | 9,060 | +410 | +4.7% | 204,800 |
2018/10/01 | 8,640 | 8,710 | 8,520 | 8,650 | -60 | -0.7% | 129,100 |
2018/09/28 | 8,740 | 8,830 | 8,670 | 8,710 | +10 | +0.1% | 143,600 |
2018/09/27 | 8,910 | 8,980 | 8,690 | 8,700 | -210 | -2.4% | 130,700 |
2018/09/26 | 8,790 | 8,920 | 8,750 | 8,910 | +170 | +1.9% | 165,100 |
2018/09/25 | 8,710 | 8,790 | 8,600 | 8,740 | +90 | +1% | 181,200 |
2018/09/21 | 8,610 | 8,680 | 8,510 | 8,650 | +70 | +0.8% | 213,600 |
2018/09/20 | 8,640 | 8,650 | 8,520 | 8,580 | -60 | -0.7% | 104,100 |
2018/09/19 | 8,510 | 8,690 | 8,400 | 8,640 | +180 | +2.1% | 166,300 |
2018/09/18 | 8,270 | 8,480 | 8,220 | 8,460 | +250 | +3% | 129,100 |
2018/09/14 | 8,140 | 8,220 | 8,120 | 8,210 | +140 | +1.7% | 159,200 |
2018/09/13 | 8,050 | 8,250 | 8,010 | 8,070 | ±0 | ±0% | 145,000 |
2018/09/12 | 8,100 | 8,120 | 8,000 | 8,070 | -90 | -1.1% | 125,500 |
2018/09/11 | 7,960 | 8,180 | 7,960 | 8,160 | +240 | +3% | 130,500 |
2018/09/10 | 7,870 | 8,010 | 7,860 | 7,920 | +60 | +0.8% | 120,300 |
2018/09/07 | 7,700 | 7,890 | 7,700 | 7,860 | +60 | +0.8% | 131,600 |
2018/09/06 | 7,960 | 7,960 | 7,770 | 7,800 | -250 | -3.1% | 131,900 |
2018/09/05 | 8,100 | 8,130 | 8,020 | 8,050 | -40 | -0.5% | 117,900 |
2018/09/04 | 8,010 | 8,130 | 7,930 | 8,090 | +70 | +0.9% | 101,600 |
2018/09/03 | 8,090 | 8,090 | 8,000 | 8,020 | -100 | -1.2% | 73,000 |
1651~
1700
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム